Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Mini Review
  • Published:

Mini-Review

Umbilical cord blood for allogeneic transplantation in children and adults

Bone Marrow Transplantation volume 27, pages 1–6 (2001)Cite this article

Abstract

Early clinical reports outlining outcomes for primarily pediatric patients undergoing UCB transplantation, point to delayed time to hematopoietic recovery, and favorable incidence and severity of graft-versus-host disease. Intensive clinical and laboratory research is ongoing focused on strategies to foster UCB allogeneic donor engraftment, thereby allowing wider application of this stem cell source for patients requiring allogeneic transplantation. Bone Marrow Transplantation (2001) 27, 1–6.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Gluckman E, Broxmeyer HE, Auerbach AD . Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling New Engl J Med 1989 17: 1174–1178

    Article  Google Scholar 

  2. Wagner JE, Kernan NA, Steinbuch M et al. Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease Lancet 1995 346: 214–219

    Article  CAS  PubMed  Google Scholar 

  3. Rocha V, Wagner JE, Sobocinski KA et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources New Engl J Med 2000 342: 1846–1854

    Article  CAS  PubMed  Google Scholar 

  4. Locatelli F, Rocha V, Chastang C et al. Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-Cord Blood Transplant Group Blood 1999 93: 3662–3667

    CAS  PubMed  Google Scholar 

  5. Gluckman E, Rocha V, Boyer-Chammard A et al. Outcome of cord-blood transplantation from related and unrelated donors New Engl J Med 1997 337: 373–381

    Article  CAS  PubMed  Google Scholar 

  6. Rubinstein P, Carrier C, Scaradavou A et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors New Engl J Med 1998 339: 1565–1577

    Article  CAS  PubMed  Google Scholar 

  7. Kurtzberg J, Laughlin M, Graham M et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients New Engl J Med 1996 335: 157–166

    Article  CAS  PubMed  Google Scholar 

  8. Wagner JE, Rosenthal J, Sweetmen R et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease Blood 1996 88: 795–802

    CAS  PubMed  Google Scholar 

  9. Kurtzberg J, Laughlin MJ, Smith CA et al. Hematopoietic recovery in adult recipients following unrelated umbilical cord blood (UCB) transplantation Blood 1997 90: 110a

    Google Scholar 

  10. Laughlin MJ, Rizzieri DA, Smith CA et al. Engraftment and reconstitution of immune function post unrelated cord blood transplant in an adult with Philadelphia chromosome positive acute lymphocytic leukemia Leukemia Res 1998 22: 215–219

    Article  CAS  Google Scholar 

  11. Laporte J, Gorin N, Rubinstein P et al. Cord-blood transplantation from an unrelated donor in an adult with chronic myelogenous leukemia New Engl J Med 1996 335: 167–170

    Article  CAS  PubMed  Google Scholar 

  12. Bertolini F, Lazzari L, Lauri E et al. Comparative study of different procedures for the collection and banking of umbilical cord blood J Hematother 1995 4: 29–36

    Article  CAS  PubMed  Google Scholar 

  13. Denning-Kendall P, Donaldson C, Nicol A et al. Optimal processing of human umbilical cord blood for clinical banking Exp Hematol 1996 24: 1394–1401

    CAS  PubMed  Google Scholar 

  14. Shlebak AA, Roberts AG, Stevens A et al. The impact of antenatal and perinatal variables on cord blood haemopoietic stem/progenitor cell yield available for transplantation Br J Haematology 1998 103: 1167–1171

    Article  CAS  Google Scholar 

  15. Fraser JK, Cairo MS, Wagner EL et al. Cord blood transplantation study (COBLT): cord blood bank standard operating procedures J Hematother 1998 7: 521–561

    Article  CAS  PubMed  Google Scholar 

  16. McCullough J, Herr G, Lennon S et al. Factors influencing the availability of umbilical cord blood for banking and transplantation Transfusion 1998 38: 508–510

    Article  CAS  PubMed  Google Scholar 

  17. Rubinstein P, Dobrila L, Rosenfield RE et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution Proc Natl Acad Sci USA 1995 92: 10119–10122

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Almici C, Carlo-Stella C, Wagner JE, Rizzoli V . Density separation and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution Acta Haematol 1996 95: 171–175

    Article  CAS  PubMed  Google Scholar 

  19. Regidor C, Posada M, Monteagudo D et al. Umbilical cord blood banking for unrelated transplantation: evaluation of cell separation and storage methods Exp Hematol 1999 27: 380–385

    Article  CAS  PubMed  Google Scholar 

  20. Cairo MS, Wagner JE . Placental and/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation Blood 1997 90: 4665–4678

    CAS  PubMed  Google Scholar 

  21. Laughlin MJ, Barker J, Bambach B et al. Hematopoietic engraftment and survival after unrelated donor umbilical cord blood transplantation in adult recipients. (Submitted)

  22. Paulin T . Importance of bone marrow cell dose in bone marrow transplantation Clin Transplant 1992 6: 48–54

    CAS  PubMed  Google Scholar 

  23. Mavroudis D, Read E, Cottler-Fox M et al. CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies Blood 1996 88: 3223–3229

    CAS  PubMed  Google Scholar 

  24. Sierra J, Storer B, Hansen JA et al. Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose Blood 1997 89: 4226–4235

    CAS  PubMed  Google Scholar 

  25. Bender JG, Unverzagt K, Walker DE et al. Phenotypic analysis and characterization of CD34+ cells from normal human bone marrow, cord blood, peripheral blood, and mobilized peripheral blood from patients undergoing autologous stem cell transplantation Clin Immunol Immunopathol 1994 70: 10–18

    Article  CAS  PubMed  Google Scholar 

  26. Petersdorf EW, Longton GM, Anasetti C et al. Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors Blood 1997 89: 1818–1823

    CAS  PubMed  Google Scholar 

  27. Bishara A, Brautbar C, Cohen I et al. Positivity in a modified mixed leukocyte reaction test correlates with molecular HLA-C disparity in prediction of unrelated bone marrow transplantation outcome Hum Immunol 1999 60: 833–839

    Article  CAS  PubMed  Google Scholar 

  28. Sasazuki T, Juji T, Morishima Y et al. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor New Engl J Med 1998 339: 1177–1185

    Article  CAS  PubMed  Google Scholar 

  29. Marijt WA, Kernan NA, Diaz-Barrientos T et al. Multiple minor histocompatibility antigen-specific cytotoxic T lymphocyte clones can be generated during graft rejection after HLA-identical bone marrow transplantation Bone Marrow Transplant 1995 16: 125–132

    CAS  PubMed  Google Scholar 

  30. Elia L, Arcese W, Torello M et al. HLA-C and HLA-DQB1 compatibility in unrelated cord blood transplants Haematologica 1999 84: 530–534

    CAS  PubMed  Google Scholar 

  31. Roy V, Verfaillie CM . Expression and function of cell adhesion molecules on fetal liver, cord blood and bone marrow hematopoietic progenitors: implications for anatomical localization and developmental stage specific regulation of hematopoiesis Exp Hematol 1999 27: 302–312

    Article  CAS  PubMed  Google Scholar 

  32. Peled A, Kollet O, Ponomaryov T et al. The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice Blood 2000 95: 3289–3296

    CAS  PubMed  Google Scholar 

  33. Pasino M, Lanza T, Marotta F et al. Flow cytometric and functional characterization of AC133+ cells from human umbilical cord blood Br J Haematol 2000 108: 793–800

    Article  CAS  PubMed  Google Scholar 

  34. Huang S, Law P, Young D, Ho AD . Candidate hematopoietic stem cells from fetal tissues, umbilical cord blood vs. adult bone marrow and mobilized peripheral blood Exp Hematol 1998 12: 1162–1171

    Google Scholar 

  35. Theilgaard-Monch K, Raaschou-Jensen K, Heilmann C et al. A comparative study of CD34+ cells, CD34+ subsets, colony forming cells and cobblestone area forming cells in cord blood and bone marrow allografts Eur J Haematol 1999 62: 174–183

    Article  CAS  PubMed  Google Scholar 

  36. Han P, Hodge G . Intracellular cytokine production and cytokine receptor interaction of cord mononuclear cell: relevance to cord blood transplantation Br J Haematol 1999 107: 450–457

    Article  CAS  PubMed  Google Scholar 

  37. Hiruma K, Nakamura H, Henkart P et al. Clonal deletion of postthymic T cell: veto cells kill precursor cytotoxic T lymphocytes J Exp Med 1992 175: 863–870

    Article  CAS  PubMed  Google Scholar 

  38. Saeland S, Duvert V, Caux C et al. Distribution of surface-membrane molecules on bone marrow and cord blood CD34+ hematopoietic cells Exp Hematol 1992 20: 24–33

    CAS  PubMed  Google Scholar 

  39. Gomi S, Hasegawa S, Dan K, Wakabayashi I . A comparative analysis of the transplant potential of umbilical cord blood versus mobilized peripheral blood stem cells Nippon Ika Daigaku Zasshi 1997 64: 307–313

    Article  CAS  PubMed  Google Scholar 

  40. Laughlin MJ, Smith CA, Martin P et al. Hematopoietic engraftment using placental cord blood (PCB) unrelated donor transplantation in recipients >40 kg weight Blood 1996 88: 266a

    Google Scholar 

  41. Weinreb S, Delgado JC, Clavijo OP et al. Transplantation of unrelated cord blood cells Bone Marrow Transplant 1998 22: 193–196

    Article  CAS  PubMed  Google Scholar 

  42. Hansen JA, Anasetti C, Beatty PG et al. Treatment of leukemia by marrow transplantation from HLA-incompatible donors. Effect of HLA-disparity on GVHD, relapse and survival Bone Marrow Transplant 1998 6: 108–111

    Google Scholar 

  43. Goulmy E, Shipper R, Pool J et al. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation New Engl J Med 1996 334: 281–285

    Article  CAS  PubMed  Google Scholar 

  44. Simpson E, Roopenian D, Goulmy E . Much ado about minor histocompatibility antigens Immunol Today 1998 19: 108–116

    Article  CAS  PubMed  Google Scholar 

  45. van der Harst D, Goulmy E, Falkenburg JHF et al. Recognition of minor histocompatibility antigens on lymphocytic and myeloid leukemic cells by cytotoxic T-cell clones Blood 1994 83: 1060–1069

    CAS  PubMed  Google Scholar 

  46. Kernan NA, Bartsch G, Ash RC et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program New Engl J Med 1993 328: 593–596

    Article  CAS  PubMed  Google Scholar 

  47. Hansen JA, Gooley TA, Martin PJ et al. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia New Engl J Med 1998 338: 962–968

    Article  CAS  PubMed  Google Scholar 

  48. McGlave PB, Shu XO, Wen W et al. Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 years’ experience of the national marrow donor program Blood 2000 95: 2219–2225

    CAS  PubMed  Google Scholar 

  49. Szydlo R, Goldman JM, Klein JP et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings J Clin Oncol 1997 15: 1767–1777

    Article  CAS  PubMed  Google Scholar 

  50. Chalmers IM, Janossy G, Contreras M, Navarrete C . Intracellular cytokine profile of cord and adult blood lymphocytes Blood 1998 92: 11–14

    CAS  PubMed  Google Scholar 

  51. D'Arena G, Musto P, Caseavilla N et al. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features Haematologica 1998 83: 197–203

    CAS  PubMed  Google Scholar 

  52. Risdon G, Gaddy J, Stehman FB et al. Proliferative and cytotoxic responses of human cord blood T lymphocytes following allogeneic stimulation Cell Immunol 1994 154: 14–24

    Article  CAS  PubMed  Google Scholar 

  53. Kadereit S, Mohammad SF, Miller R et al. Reduced NFAT1 protein expression in human umbilical cord blood T lymphocytes Blood 1999 94: 3101–3107

    CAS  PubMed  Google Scholar 

  54. Takahashi N, Imanishi K, Nishida H, Uchiyama T . Evidence for immunologic immaturity of cord blood T cells. Cord blood T cells are susceptible to tolerance induction to in vitro stimulation with a superantigen J Immunol 1995 155: 5213–5219

    CAS  PubMed  Google Scholar 

  55. Wagner JE, Kurtzberg J . Cord blood stem cells Curr Opinion Hematol 1997 4: 413–418

    Article  CAS  Google Scholar 

  56. DiGiusto DL, Lee R, Moon J et al. Hematopoietic potential of cryopreserved and ex vivo manipulated umbilical cord blood progenitor cells evaluated in vitro and in vivo Blood 2000 87: 1261–1271

    Google Scholar 

  57. Kogler G, Nurnberger W, Fischer J et al. Simultaneous cord blood transplantation of ex vivo expanded together with non-expanded cells for high risk leukemia Bone Marrow Transplant 1999 24: 397–403

    Article  CAS  PubMed  Google Scholar 

  58. Koller MR, Nurnberger W, Manchel I, Maher RJ et al. Clinical-scale human umbilical cord blood cell expansion in a novel automated perfusion culture system Bone Marrow Transplant 1998 21: 653–663

    Article  CAS  PubMed  Google Scholar 

  59. Pecora AL, Stiff P, Jennis A et al. Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using ex vivo expanded and unmanipulated unrelated umbilical cord blood Bone Marrow Transplant 2000 25: 797–799

    Article  CAS  PubMed  Google Scholar 

  60. Pierelli L, Scambia G, Fattorossi A et al. Functional, phenotypic and molecular characterization of cytokine low-responding circulating CD34+ haemopoietic progenitors Br J Haematol 1998 102: 1139–1147

    Article  CAS  PubMed  Google Scholar 

  61. Rice A, Flemming C, Case J et al. Comparative study of the in vitro behavior of cord blood subpopulations after short-term cytokine exposure Bone Marrow Transplant 1999 23: 211–220

    Article  CAS  PubMed  Google Scholar 

  62. Gandy KL, Domen J, Aguila H et al. CD8+TCR+ and CD8+TCR− cells in whole bone marrow facilitate the engraftment of hematopoietic stem cells across allogeneic barriers Immunity 1999 11: 579–590

    Article  CAS  PubMed  Google Scholar 

  63. Bonnet D, Bhatia M, Wang JC et al. Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limited doses into NOD/SCID mice Bone Marrow Transplant 1999 23: 203–209

    Article  CAS  PubMed  Google Scholar 

  64. Blazar BR, Taylor PA, Panoskaltsis-Mortari A et al. A critical role for CD48 antigen in regulating alloengraftment and lymphohematopoietic recovery after bone marrow transplantation Blood 1998 92: 4453–4463

    CAS  PubMed  Google Scholar 

  65. Welniak L, Murphy WJ, Iacobucci M et al. IL-15 increases lymphoid and myeloid engraftment of ex vivo expanded human umbilical cord blood (UCB) in NOD.SCID mice Blood 1998 92: 290b

    Google Scholar 

  66. Neipp M, Zorina T, Domenick MA et al. Effect of FLt3 ligand and granulocyte colony-stimulating factor on expansion and mobilization of facilitating cells and hematopoietic stem cells in mice: kinetics and repopulating potential Blood 1998 92: 3177–3188

    CAS  PubMed  Google Scholar 

  67. Gauthier L, Fougereau M, Tonnelle C et al. Construction of temperature and Zn-dependent human stromal cell lines that amplify hematopoietic precursors from cord blood CD34+ cells Exp Hematol 2000 26: 534–540

    Google Scholar 

  68. Jazwiec B, Solanilla A, Grosset C et al. Endothelial cell support of hematopoiesis is differentially altered by IL-1 and glucocorticoids Leukemia 1998 12: 1210–1220

    Article  CAS  PubMed  Google Scholar 

  69. Piacibello W, Sanavio F, Garetto L et al. Differential growth factor requirement of primitive cord blood hematopoietic stem cell for self-renewal and amplification vs proliferation and differentiation Leukemia 1998 12: 718–727

    Article  CAS  PubMed  Google Scholar 

  70. Koller MR, Manchel I, Palsson BO . Importance of parenchymal:stromal cell ratio for the ex vivo reconstitution of human hematopoiesis Stem Cells 1997 15: 305–313

    Article  CAS  PubMed  Google Scholar 

  71. Fagnoni FF, Vescovini R, Passeri G et al. Shortage of circulating naive CD8+ T cells provides new insights on immunodeficiency in aging Blood 2000 95: 2860–2868

    CAS  PubMed  Google Scholar 

  72. Vaziri H, Dragowska WL, Allsopp RC et al. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age Proc Natl Acad Sci USA 1994 91: 9857–9860

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Shay JW, Wright WE . Telomeres and telomerase in human leukemias Leukemia 1996 10: 1255–1261

    CAS  PubMed  Google Scholar 

  74. Sakabe H, Yhata N, Kimura T et al. Human cord blood-derived primitive progenitors are enriched in CD34+c-kit− cells: correlation between long-term culture-initiating cells and telomerase expression Leukemia 1998 12: 728–734

    Article  CAS  PubMed  Google Scholar 

  75. Engelhardt M, Kumar R, Albanell J et al. Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells Blood 1997 90: 182–193

    CAS  PubMed  Google Scholar 

  76. Morrison SJ, Prowse KR, Ho P et al. Telomerase activity in hematopoietic cells is associated with self-renewal potential Immunity 1996 5: 207–216

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

MJL is a Stephen Birnbaum Translational Research Investigator of the Leukemia and Lymphoma Society of America and Leukemia Scholar in Clinical Research (Grant No. 6230–98).

Author information

Authors and Affiliations

  1. Department of Medicine, Case Western Reserve University, University Hospitals Ireland Cancer Center, Cleveland, Ohio, USA

    MJ Laughlin

Authors
  1. MJ Laughlin
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Laughlin, M. Umbilical cord blood for allogeneic transplantation in children and adults. Bone Marrow Transplant 27, 1–6 (2001). https://doi.org/10.1038/sj.bmt.1702740

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702740

Keywords

This article is cited by

Search

Advanced search

Quick links